Previous Close | 45.36 |
Open | 45.75 |
Bid | 44.65 x 200 |
Ask | 44.87 x 100 |
Day's Range | 44.62 - 46.06 |
52 Week Range | 32.69 - 52.69 |
Volume | |
Avg. Volume | 106,064 |
Market Cap | 893.325M |
Beta (5Y Monthly) | 0.71 |
PE Ratio (TTM) | 85.96 |
EPS (TTM) | 0.52 |
Earnings Date | Jul 04, 2024 - Jul 08, 2024 |
Forward Dividend & Yield | 0.24 (0.53%) |
Ex-Dividend Date | Apr 26, 2024 |
1y Target Est | 53.67 |
For the seventh consecutive year, the FDA has renewed Simulations Plus' (SLP) license to the DILIsym software system for facilitating drug safety evaluations.
Simulations Plus, Inc. ( NASDAQ:SLP ) investors will be delighted, with the company turning in some strong numbers with...
Simulations Plus ( NASDAQ:SLP ) Second Quarter 2024 Results Key Financial Results Revenue: US$18.3m (up 16% from 2Q...